China Klebsiella Pneumoniae Infection Drug Market Research Report 2018

China Klebsiella Pneumoniae Infection Drug Market Research Report 2017

1 Klebsiella Pneumoniae Infection Drug Overview

1.1 Product Overview and Scope of Klebsiella Pneumoniae Infection Drug

1.2 Classification of Klebsiella Pneumoniae Infection Drug by Product Category

1.2.1 China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) Comparison by Type (2012-2022)

1.2.2 China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) Market Share by Type in 2016

1.2.3 ATI-1503

1.2.4 CA-824

1.2.5 CC-1807

1.2.6 Cefiderocol

1.2.7 Debio-1454

1.2.8 EBX-004

1.2.9 Others

1.3 China Klebsiella Pneumoniae Infection Drug Market by Application/End Users

1.3.1 China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Market Share Comparison by Applications (2012-2022)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 China Klebsiella Pneumoniae Infection Drug Market by Region

1.4.1 China Klebsiella Pneumoniae Infection Drug Market Size (Million USD) Comparison by Region (2012-2022)

1.4.2 South China Klebsiella Pneumoniae Infection Drug Status and Prospect (2012-2022)

1.4.3 East China Klebsiella Pneumoniae Infection Drug Status and Prospect (2012-2022)

1.4.4 Southwest China Klebsiella Pneumoniae Infection Drug Status and Prospect (2012-2022)

1.4.5 Northeast China Klebsiella Pneumoniae Infection Drug Status and Prospect (2012-2022)

1.4.6 North China Klebsiella Pneumoniae Infection Drug Status and Prospect (2012-2022)

1.4.7 Central China Klebsiella Pneumoniae Infection Drug Status and Prospect (2012-2022)

1.5 China Market Size (Sales and Revenue) of Klebsiella Pneumoniae Infection Drug (2012-2022)

1.5.1 China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%)(2012-2022)

1.5.2 China Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 China Klebsiella Pneumoniae Infection Drug Market Competition by Players/Manufacturers

2.1 China Klebsiella Pneumoniae Infection Drug Sales and Market Share of Key Players/Manufacturers (2012-2017)

2.2 China Klebsiella Pneumoniae Infection Drug Revenue and Share by Players/Manufacturers (2012-2017)

2.3 China Klebsiella Pneumoniae Infection Drug Average Price (USD/Pcs) by Players/Manufacturers (2012-2017)

2.4 China Klebsiella Pneumoniae Infection Drug Market Competitive Situation and Trends

2.4.1 China Klebsiella Pneumoniae Infection Drug Market Concentration Rate

2.4.2 China Klebsiella Pneumoniae Infection Drug Market Share of Top 3 and Top 5 Players/Manufacturers

2.4.3 Mergers & Acquisitions, Expansion in China Market

2.5 China Players/Manufacturers Klebsiella Pneumoniae Infection Drug Manufacturing Base Distribution, Sales Area, Product Types

3 China Klebsiella Pneumoniae Infection Drug Sales and Revenue by Region (2012-2017)

3.1 China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Market Share by Region (2012-2017)

3.2 China Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Market Share by Region (2012-2017)

3.3 China Klebsiella Pneumoniae Infection Drug Price (USD/Pcs) by Regions (2012-2017)

4 China Klebsiella Pneumoniae Infection Drug Sales and Revenue by Type/ Product Category (2012-2017)

4.1 China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Market Share by Type/ Product Category (2012-2017)

4.2 China Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Market Share by Type (2012-2017)

4.3 China Klebsiella Pneumoniae Infection Drug Price (USD/Pcs) by Type (2012-2017)

4.4 China Klebsiella Pneumoniae Infection Drug Sales Growth Rate (%) by Type (2012-2017)

5 China Klebsiella Pneumoniae Infection Drug Sales by Application (2012-2017)

5.1 China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Market Share by Application (2012-2017)

5.2 China Klebsiella Pneumoniae Infection Drug Sales Growth Rate (%) by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 China Klebsiella Pneumoniae Infection Drug Players/Suppliers Profiles and Sales Data

6.1 Acies Bio doo

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Acies Bio doo Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

6.1.4 Main Business/Business Overview

6.2 Appili Therapeutics

6.2.1 Company Basic Information, Manufacturing Base and Competitors

6.2.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Appili Therapeutics Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

6.2.4 Main Business/Business Overview

6.3 Debiopharm International SA

6.3.1 Company Basic Information, Manufacturing Base and Competitors

6.3.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Debiopharm International SA Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

6.3.4 Main Business/Business Overview

6.4 Evaxion Biotech ApS

6.4.1 Company Basic Information, Manufacturing Base and Competitors

6.4.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

6.4.4 Main Business/Business Overview

6.5 F. Hoffmann-La Roche Ltd

6.5.1 Company Basic Information, Manufacturing Base and Competitors

6.5.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

6.5.4 Main Business/Business Overview

6.6 FOB Synthesis Inc

6.6.1 Company Basic Information, Manufacturing Base and Competitors

6.6.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

6.6.4 Main Business/Business Overview

6.7 ImmunoClin Corp

6.7.1 Company Basic Information, Manufacturing Base and Competitors

6.7.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

6.7.4 Main Business/Business Overview

6.8 Innovation Pharmaceuticals Inc

6.8.1 Company Basic Information, Manufacturing Base and Competitors

6.8.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

6.8.4 Main Business/Business Overview

6.9 Kyorin Pharmaceutical Co Ltd

6.9.1 Company Basic Information, Manufacturing Base and Competitors

6.9.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

6.9.4 Main Business/Business Overview

6.10 Melinta Therapeutics Inc

6.10.1 Company Basic Information, Manufacturing Base and Competitors

6.10.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

6.10.4 Main Business/Business Overview

6.11 Nosopharm SAS

6.12 Peptilogics Inc

6.13 Pfizer Inc

6.14 Phico Therapeutics Ltd

6.15 Sarepta Therapeutics Inc

6.16 Shionogi & Co Ltd

6.17 Syntiron LLC

6.18 Tetraphase Pharmaceuticals Inc

7 Klebsiella Pneumoniae Infection Drug Manufacturing Cost Analysis

7.1 Klebsiella Pneumoniae Infection Drug Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Klebsiella Pneumoniae Infection Drug

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Klebsiella Pneumoniae Infection Drug Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Klebsiella Pneumoniae Infection Drug Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 China Klebsiella Pneumoniae Infection Drug Market Size (Sales and Revenue) Forecast (2017-2022)

11.1 China Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)

11.2 China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) Forecast by Type (2017-2022)

11.3 China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) Forecast by Application (2017-2022)

11.4 China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Methodology and Data Source

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

13.4 Author List

Figure Global and China Market Size (Million USD) Comparison (2012-2022)

Table Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Revenue (Million USD) Market Split by Product Type

Table Klebsiella Pneumoniae Infection Drug Sales (K Pcs) by Application (2016-2022)

Figure Product Picture of Klebsiella Pneumoniae Infection Drug

Table China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)

Figure China Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Types in 2016

Figure ATI-1503 Product Picture

Figure CA-824 Product Picture

Figure CC-1807 Product Picture

Figure Cefiderocol Product Picture

Figure Debio-1454 Product Picture

Figure EBX-004 Product Picture

Figure Others Product Picture

Figure China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) Comparison by Application (2012-2022)

Figure China Sales Market Share (%) of Klebsiella Pneumoniae Infection Drug by Application in 2016

Figure Hospital Examples

Table Key Downstream Customer in Hospital

Figure Clinic Examples

Table Key Downstream Customer in Clinic

Figure Others Examples

Table Key Downstream Customer in Others

Figure South China Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure East China Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest China Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure Northeast China Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure North China Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure Central China Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%)(2012-2022)

Figure China Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (%)(2012-2022)

Table China Klebsiella Pneumoniae Infection Drug Sales of Key Players/Manufacturers (2012-2017)

Table China Klebsiella Pneumoniae Infection Drug Sales Share (%) by Players/Manufacturers (2012-2017)

Figure 2016 China Klebsiella Pneumoniae Infection Drug Sales Share (%) by Players/Manufacturers

Figure 2017 China Klebsiella Pneumoniae Infection Drug Sales Share (%) by Players/Manufacturers

Table China Klebsiella Pneumoniae Infection Drug Revenue by Players/Manufacturers (2012-2017)

Table China Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) by Players/Manufacturers (2012-2017)

Figure 2016 China Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) by Players/Manufacturers

Figure 2017 China Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) by Players/Manufacturers

Table China Market Klebsiella Pneumoniae Infection Drug Average Price of Key Players/Manufacturers (2012-2017)

Figure China Market Klebsiella Pneumoniae Infection Drug Average Price of Key Players/Manufacturers in 2016

Figure China Klebsiella Pneumoniae Infection Drug Market Share of Top 3 Players/Manufacturers

Figure China Klebsiella Pneumoniae Infection Drug Market Share of Top 5 Players/Manufacturers

Table China Players/Manufacturers Klebsiella Pneumoniae Infection Drug Manufacturing Base Distribution and Sales Area

Table China Players/Manufacturers Klebsiella Pneumoniae Infection Drug Product Category

Table China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) by Regions (2012-2017)

Table China Klebsiella Pneumoniae Infection Drug Sales Share (%) by Regions (2012-2017)

Figure China Klebsiella Pneumoniae Infection Drug Sales Share (%) by Regions (2012-2017)

Figure China Klebsiella Pneumoniae Infection Drug Sales Market Share (%) by Regions in 2016

Table China Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Market Share by Regions (2012-2017)

Table China Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) by Regions (2012-2017)

Figure China Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) by Regions (2012-2017)

Figure China Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) by Regions in 2016

Table China Klebsiella Pneumoniae Infection Drug Price (USD/Pcs) by Regions (2012-2017)

Table China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) by Type (2012-2017)

Table China Klebsiella Pneumoniae Infection Drug Sales Share (%) by Type (2012-2017)

Figure China Klebsiella Pneumoniae Infection Drug Sales Share (%) by Type (2012-2017)

Figure China Klebsiella Pneumoniae Infection Drug Sales Market Share (%) by Type in 2016

Table China Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Market Share by Type (2012-2017)

Table China Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) by Type (2012-2017)

Figure Revenue Market Share of Klebsiella Pneumoniae Infection Drug by Type (2012-2017)

Figure Revenue Market Share of Klebsiella Pneumoniae Infection Drug by Type in 2016

Table China Klebsiella Pneumoniae Infection Drug Price (USD/Pcs) by Types (2012-2017)

Figure China Klebsiella Pneumoniae Infection Drug Sales Growth Rate (%) by Type (2012-2017)

Table China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) by Applications (2012-2017)

Table China Klebsiella Pneumoniae Infection Drug Sales Market Share (%) by Applications (2012-2017)

Figure China Klebsiella Pneumoniae Infection Drug Sales Market Share (%) by Application (2012-2017)

Figure China Klebsiella Pneumoniae Infection Drug Sales Market Share (%) by Application in 2016

Table China Klebsiella Pneumoniae Infection Drug Sales Growth Rate (%) by Application (2012-2017)

Figure China Klebsiella Pneumoniae Infection Drug Sales Growth Rate (%) by Application (2012-2017)

Table Acies Bio doo Klebsiella Pneumoniae Infection Drug Basic Information List

Table Acies Bio doo Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

Figure Acies Bio doo Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)

Figure Acies Bio doo Klebsiella Pneumoniae Infection Drug Sales Market Share (%) in China (2012-2017)

Figure Acies Bio doo Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) in China (2012-2017)

Table Appili Therapeutics Klebsiella Pneumoniae Infection Drug Basic Information List

Table Appili Therapeutics Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

Figure Appili Therapeutics Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)

Figure Appili Therapeutics Klebsiella Pneumoniae Infection Drug Sales Market Share (%) in China (2012-2017)

Figure Appili Therapeutics Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) in China (2012-2017)

Table Debiopharm International SA Klebsiella Pneumoniae Infection Drug Basic Information List

Table Debiopharm International SA Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

Figure Debiopharm International SA Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)

Figure Debiopharm International SA Klebsiella Pneumoniae Infection Drug Sales Market Share (%) in China (2012-2017)

Figure Debiopharm International SA Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) in China (2012-2017)

Table Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Basic Information List

Table Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

Figure Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)

Figure Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Sales Market Share (%) in China (2012-2017)

Figure Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) in China (2012-2017)

Table F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Basic Information List

Table F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

Figure F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)

Figure F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Sales Market Share (%) in China (2012-2017)

Figure F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) in China (2012-2017)

Table FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Basic Information List

Table FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

Figure FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)

Figure FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Sales Market Share (%) in China (2012-2017)

Figure FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) in China (2012-2017)

Table ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Basic Information List

Table ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

Figure ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)

Figure ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Sales Market Share (%) in China (2012-2017)

Figure ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) in China (2012-2017)

Table Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Basic Information List

Table Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

Figure Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)

Figure Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales Market Share (%) in China (2012-2017)

Figure Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) in China (2012-2017)

Table Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Basic Information List

Table Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

Figure Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)

Figure Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Sales Market Share (%) in China (2012-2017)

Figure Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) in China (2012-2017)

Table Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Basic Information List

Table Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)

Figure Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)

Figure Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales Market Share (%) in China (2012-2017)

Figure Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) in China (2012-2017)

Table Nosopharm SAS Klebsiella Pneumoniae Infection Drug Basic Information List

Table Peptilogics Inc Klebsiella Pneumoniae Infection Drug Basic Information List

Table Pfizer Inc Klebsiella Pneumoniae Infection Drug Basic Information List

Table Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Basic Information List

Table Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Basic Information List

Table Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Basic Information List

Table Syntiron LLC Klebsiella Pneumoniae Infection Drug Basic Information List

Table Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Klebsiella Pneumoniae Infection Drug

Figure Manufacturing Process Analysis of Klebsiella Pneumoniae Infection Drug

Figure Klebsiella Pneumoniae Infection Drug Industrial Chain Analysis

Table Raw Materials Sources of Klebsiella Pneumoniae Infection Drug Major Players/Manufacturers in 2016

Table Major Buyers of Klebsiella Pneumoniae Infection Drug

Table Distributors/Traders List

Figure China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)

Figure China Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure China Klebsiella Pneumoniae Infection Drug Price (USD/Pcs) Trend Forecast (2017-2022)

Table China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) Forecast by Type (2017-2022)

Figure China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) Forecast by Type (2017-2022)

Figure China Klebsiella Pneumoniae Infection Drug Sales Volume Market Share Forecast by Type in 2022

Table China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) Forecast by Application (2017-2022)

Figure China Klebsiella Pneumoniae Infection Drug Sales Volume Market Share Forecast by Application (2017-2022)

Figure China Klebsiella Pneumoniae Infection Drug Sales Volume Market Share Forecast by Application in 2022

Table China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) Forecast by Regions (2017-2022)

Table China Klebsiella Pneumoniae Infection Drug Sales Volume Share Forecast by Regions (2017-2022)

Figure China Klebsiella Pneumoniae Infection Drug Sales Volume Share Forecast by Regions (2017-2022)

Figure China Klebsiella Pneumoniae Infection Drug Sales Volume Share Forecast by Regions in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources